Keywords: Vivus, Qsymia, Discount program, Obesity, Weight management, USA

Vivus announces new discount program for obesity drug Qsymia

Article | 06 March 2013

Print This

US drugmaker Vivus (Nasdaq: VVUS) has announced a new program offering eligible patients a discount on its recently launched weight ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in